Total Payments
$5,395
2024 Payments
$573.65
Companies
40
Transactions
347
Medicare Patients
11,390
Medicare Billing
$548,136
Payment Breakdown by Category
Food & Beverage$5,395 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,395 | 347 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $793.26 | 60 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $779.97 | 50 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $442.68 | 25 | $0 (2023) |
| PFIZER INC. | $394.78 | 25 | $0 (2024) |
| Lilly USA, LLC | $389.13 | 27 | $0 (2024) |
| ABBVIE INC. | $363.45 | 24 | $0 (2024) |
| Amgen Inc. | $359.73 | 22 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $204.50 | 15 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $178.76 | 13 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $177.10 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $573.65 | 32 | Novo Nordisk Inc ($157.79) |
| 2023 | $311.44 | 17 | AstraZeneca Pharmaceuticals LP ($101.14) |
| 2022 | $637.59 | 36 | Novo Nordisk Inc ($111.28) |
| 2021 | $795.51 | 47 | AstraZeneca Pharmaceuticals LP ($167.23) |
| 2020 | $578.69 | 38 | Amarin Pharma Inc. ($91.18) |
| 2019 | $754.95 | 58 | Novo Nordisk Inc ($141.86) |
| 2018 | $694.19 | 50 | Novo Nordisk Inc ($107.15) |
| 2017 | $1,049 | 69 | Novartis Pharmaceuticals Corporation ($131.78) |
All Payment Transactions
347 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.91 | General |
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Obesity | ||||||
| 08/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.80 | General |
| 07/31/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Obesity | ||||||
| 07/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/07/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: WOMENS HEALTH | ||||||
| 05/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: PSYCHIATRY | ||||||
| 03/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Inflammation | ||||||
| 03/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Diabetes | ||||||
| 02/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
| 02/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.39 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,730 | 3,917 | $385,002 | $146,111 |
| 2022 | 33 | 2,832 | 4,078 | $380,952 | $143,888 |
| 2021 | 29 | 2,925 | 4,327 | $391,736 | $136,582 |
| 2020 | 34 | 2,903 | 4,335 | $385,296 | $121,555 |
Total Patients
11,390
Total Services
16,657
Medicare Billing
$548,136
Procedure Codes
127
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 245 | 480 | $162,240 | $57,102 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 206 | 206 | $41,200 | $26,611 | 64.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 222 | $55,722 | $18,839 | 33.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 25 | 26 | $17,420 | $7,321 | 42.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 234 | 514 | $7,670 | $4,286 | 55.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 213 | 311 | $14,928 | $4,069 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 66 | $11,154 | $3,813 | 34.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 171 | 226 | $13,560 | $3,706 | 27.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 156 | 156 | $4,680 | $2,888 | 61.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 144 | 279 | $9,765 | $2,639 | 27.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 194 | 236 | $8,968 | $2,433 | 27.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 189 | 252 | $7,056 | $1,918 | 27.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 137 | 225 | $6,750 | $1,858 | 27.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 25 | 25 | $4,375 | $1,798 | 41.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 24 | $2,520 | $1,194 | 47.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $1,080 | $814.05 | 75.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 120 | 143 | $3,003 | $809.38 | 27.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 25 | 26 | $1,040 | $783.90 | 75.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 120 | 144 | $2,736 | $731.52 | 26.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 11 | 11 | $880.00 | $430.43 | 48.9% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 20 | 20 | $1,340 | $378.40 | 28.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 18 | 23 | $1,242 | $339.94 | 27.4% |
| 83735 | Magnesium level | Office | 2023 | 24 | 41 | $984.00 | $269.37 | 27.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 93 | 115 | $920.00 | $253.00 | 27.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 18 | $1,026 | $161.42 | 15.7% |
About Dr. Gloria Jackson, M.D
Dr. Gloria Jackson, M.D is a Family Medicine healthcare provider based in Grafton, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1235123423.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gloria Jackson, M.D has received a total of $5,395 in payments from pharmaceutical and medical device companies, with $573.65 received in 2024. These payments were reported across 347 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($5,395).
As a Medicare-enrolled provider, Jackson has provided services to 11,390 Medicare beneficiaries, totaling 16,657 services with total Medicare billing of $548,136. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Grafton, VA
- Active Since 09/02/2005
- Last Updated 02/07/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1235123423
Products in Payments
- FARXIGA (Drug) $649.65
- JARDIANCE (Drug) $447.33
- Ozempic (Drug) $348.91
- ELIQUIS (Drug) $245.70
- TRULICITY (Drug) $184.56
- NURTEC ODT (Drug) $173.42
- Saxenda (Drug) $162.55
- Vascepa (Drug) $153.20
- ENTRESTO (Drug) $149.00
- Trintellix (Drug) $141.87
- UBRELVY (Drug) $136.06
- JANUVIA (Drug) $135.88
- Prolia (Biological) $132.24
- Synthroid (Drug) $123.36
- TRINTELLIX (Drug) $109.79
- SHINGRIX (Biological) $106.20
- CHANTIX (Drug) $99.63
- SYMBICORT (Drug) $79.39
- Wegovy (Drug) $75.93
- Repatha (Biological) $71.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Grafton
John Hollingsworth, M.d, M.D
Family Medicine — Payments: $2,211
Family Medicine $2,211
Dr. Michael Hess, M.d, M.D
Family Medicine — Payments: $2,186
Family Medicine $2,186
Dr. Jennifer Shaw, M.d, M.D
Family Medicine — Payments: $2,164
Family Medicine $2,164
Mr. Gregory Selasky, Ms, P.a.-C, MS, P.A.-C
Family Medicine — Payments: $1,974
Family Medicine $1,974
David Bender, Md, MD
Family Medicine — Payments: $1,676
Family Medicine $1,676
Dr. Matthew Viscito, M.d, M.D
Family Medicine — Payments: $1,414
Family Medicine $1,414